Target intelligence / Profile preview

Novel transcript, sense intronic to CTIF (ENSG00000300561)

Target
ENSG00000300561
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

This entity represents a long non-coding RNA (lncRNA) that is transcribed in the sense (coding) direction within an intron of the gene CTIF (Cap-binding complex-dependent translation initiation factor). It has only been annotated based on high-throughput transcriptomic data, without experimental validation for protein-coding potential, cellular function, or disease association. Such lncRNAs are often computationally discovered, and while they add to the landscape of human transcriptomics, their roles remain speculative until further research confirms function, clinical relevance, or therapeutic applicability.\nENSG00000300561 is a computationally-predicted lncRNA, not an established molecular target like a receptor, enzyme, or transporter. It does not have drug interactions, mechanisms, or recognized biological/disease roles. Its annotation is preliminary, and the entry is likely inappropriate for structured drug discovery or therapeutic targeting.

Other names
Novel transcript, sense intronic to CTIFENSG00000300561
02

Mechanism of action

None

03

Biological functions

Other
04

Disease associations

Other

Beyond the preview

Go deeper on Novel transcript, sense intronic to CTIF (ENSG00000300561).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, sense intronic to CTIF (ENSG00000300561).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call